GERON CORP Operating Lease Right-of-Use Assets
GERON CORP (GERN) had Operating Lease Right-of-Use Assets of $1.76 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-05
- 2026-06-30: Operating Lease, Right-of-Use Asset $1.76M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $1.96M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $2.15M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $2.34M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $1.76M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $1.96M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $2.15M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $2.34M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.52M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $2.70M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $2.88M 10-K · filed 2026-03-02 |
| 2024-09-30 | $3.06M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.23M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.39M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $3.56M 10-K · filed 2025-02-27 |
| 2023-09-30 | $3.68M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $3.84M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $4.00M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.15M 10-K · filed 2024-02-28 |
| 2022-09-30 | $4.30M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $4.44M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $4.59M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $4.73M 10-K · filed 2023-03-16 |
| 2021-09-30 | $4.89M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.03M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $5.16M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $5.29M 10-K · filed 2022-03-10 |
| 2020-09-30 | $5.42M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $5.49M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $5.83M 10-Q · filed 2020-05-28 |
| 2019-12-31 | $2.50M 10-K · filed 2021-03-11 |
| 2019-09-30 | $349.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $402.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $571.00K 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |